+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2023-2030- Product Image
Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2023-2030- Product Image
Sale

Global Gene Synthesis Market by Product (Hardware, Services, Software), Method (Chip-Based Synthesis, PCR-Based Enzyme Synthesis, Solid-Phase Synthesis), Gene Type, Application, End-use - Forecast 2023-2030

  • PDF Icon

    Report

  • 183 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5715509
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gene Synthesis Market size was estimated at USD 3.84 billion in 2022, USD 4.24 billion in 2023, and is expected to grow at a CAGR of 10.75% to reach USD 8.70 billion by 2030.

The gene synthesis market comprises technologies, products, and services related to the artificial creation of DNA sequences through chemical methods in various industries such as research, medicine, agriculture, and biotechnology. Key end-users include academic institutions, pharmaceutical and biotechnology companies, government agencies, and contract research organizations (CROs). The growing prevalence of chronic conditions among the global population and rising demand for personalized medicines, along with advancements in genomics research, are driving this market. Moreover, the advantage of gene synthesis over traditional methods is fueling market growth. However, strict regulations governing the development and commercialization of GMOs and technical challenges such as limitations in size and complexity of synthetic genes limit the growth of the gene synthesis market. Emerging technologies in gene synthesis for efficiency and accuracy and the growing utilization of gene synthesis in energy and agriculture industries are creating significant growth opportunities in the market.

Regional Insights

The gene synthesis market in the Americas is highly developing owing to the presence of a developed healthcare sector and supportive government programs, which has resulted in considerable product development and the commercialization of gene synthesis technologies in the United States and Canada. This is attributed to growing improvements in R&D facilities, available disposable income, and rapidly developing economic conditions. Moreover, federal agencies and authorities have launched several initiatives, programs, and schemes to encourage gene therapy research in the region, creating a platform for gene synthesis in the Americas. Emerging economies such as India, China, Singapore, and Malaysia are potential markets for market expansion due to improved healthcare standards. These economies have a considerable presence of domestic manufacturers of gene synthesis, which contributes to an upsurge in the market penetration of multinational giants. The growing prevalence of chronic diseases, increasing technological advancements, and improved healthcare infrastructure are the primary reasons driving the gene synthesis market in EMEA. Governments across the region have been continuously investing in gene therapies, thereby expanding the utilization of various gene syntheses. In February 2022, the Dutch government invested USD 55.04 million to build a new national pilot factory to advance the development and manufacturing of promising cell and gene therapies. The investment by the Dutch government is expected to provide excellent opportunities for cell and gene therapy companies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Gene Synthesis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Gene Synthesis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Gene Synthesis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Ansa Biotechnologies, Inc., Applied Biological Materials Inc., AstraZeneca PLC, Azenta, Inc., Barcode Biosciences Private Limited, BGI Genomics by BGI Group, BioCat GmbH by AddLife AB, Biomatik Corporation, Bioneer Corporation, Biotage AB, Biotech Desk Pvt. Ltd., Boster Biological Technology, Brooks Automation Inc., Camena Bioscience, Charles River Laboratories International, Inc., Constructive Bio Ltd, Creative Biogene, Danaher Corporation, DNA TwoPointO Inc., Elabscience Biotechnology Inc., Elegen Corp., Eurofins Scientific SE, Evonetix Ltd., GenCefe Biotech Limited, Gene Universal, Inc., General Biosystems, Inc., GenScript Biotech Corporation, Ginkgo Bioworks Holdings, Inc., Macrogen, Inc., Merck KGaA, NZYTech, Lda., OriGene Technologies, Inc., ProMab Biotechnologies, Inc., ProteoGenix SAS, QIAGEN N.V., Synbio Technologies LLC, Telesis Bio Inc., Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Hardware
    • Services
      • Antibody DNA Synthesis
      • Viral DNA Synthesis
    • Software
  • Method
    • Chip-Based Synthesis
    • PCR-Based Enzyme Synthesis
    • Solid-Phase Synthesis
  • Gene Type
    • Complex Gene
    • Express Gene
    • Standard Gene
  • Application
    • Disease Diagnosis
    • Gene & Cell Therapy Development
    • Vaccine Development
  • End-use
    • Academic & Government Research Institutes
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Gene Synthesis Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Gene Synthesis Market?
  3. What are the technology trends and regulatory frameworks in the Gene Synthesis Market?
  4. What is the market share of the leading vendors in the Gene Synthesis Market?
  5. Which modes and strategic moves are suitable for entering the Gene Synthesis Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Gene Synthesis Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic conditions among the global population
5.1.1.2. Increasing genomics research activities and rising focus on personalized medicines
5.1.1.3. Growing investments by the private and public sectors in pharmaceutical research
5.1.2. Restraints
5.1.2.1. Strict regulations governing gene synthesis and high cost associated with the process
5.1.3. Opportunities
5.1.3.1. Emerging new technologies in gene synthesis
5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
5.1.4. Challenges
5.1.4.1. Limitations in size and complexity of synthetic genes
5.2. Market Segmentation Analysis
5.2.1. Product: Expanding usage of software that helps design synthetic genes accurately
5.2.2. Method: Rising utilization of chip-based synthesis for large-scale projects
5.2.3. Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
5.2.4. End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
5.2.5. Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms
5.3. Market Trend Analysis
5.3.1. Ongoing technological advancements to increase the speed of synthetic gene production coupled with a strong foothold of major players in the Americas region
5.3.2. Robust R&D activities in biotechnology and pharmaceutical sectors and the rising need for synthetic gene applications in the Asia-Pacific
5.3.3. Supportive government initiatives for genomic projects and advancing use of gene synthesis in agricultural sector in EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Gene Synthesis Market, by Product
6.1. Introduction
6.2. Hardware
6.3. Services
6.4.1. Antibody DNA Synthesis
6.4.2. Viral DNA Synthesis
6.4. Software
7. Gene Synthesis Market, by Method
7.1. Introduction
7.2. Chip-Based Synthesis
7.3. PCR-Based Enzyme Synthesis
7.4. Solid-Phase Synthesis
8. Gene Synthesis Market, by Gene Type
8.1. Introduction
8.2. Complex Gene
8.3. Express Gene
8.4. Standard Gene
9. Gene Synthesis Market, by Application
9.1. Introduction
9.2. Disease Diagnosis
9.3. Gene & Cell Therapy Development
9.4. Vaccine Development
10. Gene Synthesis Market, by End-use
10.1. Introduction
10.2. Academic & Government Research Institutes
10.3. Biotechnology & Pharmaceutical Companies
10.4. Contract Research Organizations
11. Americas Gene Synthesis Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Gene Synthesis Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Gene Synthesis Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. Merger & Acquisition
14.3.1.1. Bruker to Buy PhenomeX For USD 108 Million
14.3.2. Agreement, Collaboration, & Partnership
14.3.2.1. Evonetix and Analog Devices Inc To Progress Revolutionary Gene Synthesis Platform
14.3.2.2. Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency With New Automated Solution
14.3.2.3. Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan
14.3.3. New Product Launch & Enhancement
14.3.3.1. Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
14.3.3.2. Elegen Launches ENFINIA DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
14.3.3.3. Ansa Biotechnologies Announces Successful de novo Synthesis of Oligonucleotide at 1005 Bases
14.3.3.4. Eurofins Genomics Blue Heron launches IVT mRNA Synthesis Service: The Future of Gene Expression
14.3.4. Investment & Funding
14.3.4.1. Biotech Firm Closes GBP 5.6 million Seed Financing
14.3.4.2. Series Funding to Support Expansion of DNA Synthesis Technology
14.3.4.3. NunaBio Raises GBP 1.9M In Seed Funding To Expand Infrastructure And Accelerate R&D
14.3.4.4. Evonetix Closes USD 24 million Financing
14.3.5. Award, Recognition, & Expansion
14.3.5.1. GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
14.3.5.2. Gene Synthesis (End-to-End) Now In India At Barcode Biosciences
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Agilent Technologies, Inc.
15.1.2. Ansa Biotechnologies, Inc.
15.1.3. Applied Biological Materials Inc.
15.1.4. AstraZeneca PLC
15.1.5. Azenta, Inc.
15.1.6. Barcode Biosciences Private Limited
15.1.7. BGI Genomics by BGI Group
15.1.8. BioCat GmbH by AddLife AB
15.1.9. Biomatik Corporation
15.1.10. Bioneer Corporation
15.1.11. Biotage AB
15.1.12. Biotech Desk Pvt. Ltd.
15.1.13. Boster Biological Technology
15.1.14. Brooks Automation Inc.
15.1.15. Camena Bioscience
15.1.16. Charles River Laboratories International, Inc.
15.1.17. Constructive Bio Ltd
15.1.18. Creative Biogene
15.1.19. Danaher Corporation
15.1.20. DNA TwoPointO Inc.
15.1.21. Elabscience Biotechnology Inc.
15.1.22. Elegen Corp.
15.1.23. Eurofins Scientific SE
15.1.24. Evonetix Ltd.
15.1.25. GenCefe Biotech Limited
15.1.26. Gene Universal, Inc.
15.1.27. General Biosystems, Inc.
15.1.28. GenScript Biotech Corporation
15.1.29. Ginkgo Bioworks Holdings, Inc.
15.1.30. Macrogen, Inc.
15.1.31. Merck KGaA
15.1.32. NZYTech, Lda.
15.1.33. OriGene Technologies, Inc.
15.1.34. ProMab Biotechnologies, Inc.
15.1.35. ProteoGenix SAS
15.1.36. QIAGEN N.V.
15.1.37. Synbio Technologies LLC
15.1.38. Telesis Bio Inc.
15.1.39. Thermo Fisher Scientific Inc.
15.1.40. Twist Bioscience Corporation
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GENE SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. GENE SYNTHESIS MARKET SIZE, 2022 VS 2030
FIGURE 3. GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GENE SYNTHESIS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GENE SYNTHESIS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GENE SYNTHESIS MARKET DYNAMICS
FIGURE 7. GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GENE SYNTHESIS MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
FIGURE 10. GENE SYNTHESIS MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2022 VS 2030 (%)
FIGURE 12. GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 14. GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. GENE SYNTHESIS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 16. GENE SYNTHESIS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 20. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 26. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 9. GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 13. GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 17. GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 25. GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 49. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 50. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 55. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 56. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 81. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 82. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 83. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 87. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 88. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 89. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 99. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 100. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 101. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 136. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 137. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 155. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 156. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 158. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 160. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 161. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 162. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 164. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 166. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 167. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 168. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 170. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 172. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 173. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 174. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 176. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 178. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 179. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 188. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 190. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 191. ITALY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 192. ITALY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. ITALY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 206. NORWAY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 207. NORWAY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 208. NORWAY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 209. NORWAY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 210. NORWAY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. NORWAY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 212. POLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. POLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. POLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 215. POLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 216. POLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. POLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 218. QATAR GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. QATAR GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 220. QATAR GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 221. QATAR GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 222. QATAR GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. QATAR GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 242. SPAIN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. SPAIN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 244. SPAIN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 245. SPAIN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 246. SPAIN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. SPAIN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. TURKEY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 262. TURKEY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 263. TURKEY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. TURKEY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 278. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 279. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 280. GENE SYNTHESIS MARKET LICENSE & PRICING

Companies Mentioned

  • Agilent Technologies, Inc.
  • Ansa Biotechnologies, Inc.
  • Applied Biological Materials Inc.
  • AstraZeneca PLC
  • Azenta, Inc.
  • Barcode Biosciences Private Limited
  • BGI Genomics by BGI Group
  • BioCat GmbH by AddLife AB
  • Biomatik Corporation
  • Bioneer Corporation
  • Biotage AB
  • Biotech Desk Pvt. Ltd.
  • Boster Biological Technology
  • Brooks Automation Inc.
  • Camena Bioscience
  • Charles River Laboratories International, Inc.
  • Constructive Bio Ltd
  • Creative Biogene
  • Danaher Corporation
  • DNA TwoPointO Inc.
  • Elabscience Biotechnology Inc.
  • Elegen Corp.
  • Eurofins Scientific SE
  • Evonetix Ltd.
  • GenCefe Biotech Limited
  • Gene Universal, Inc.
  • General Biosystems, Inc.
  • GenScript Biotech Corporation
  • Ginkgo Bioworks Holdings, Inc.
  • Macrogen, Inc.
  • Merck KGaA
  • NZYTech, Lda.
  • OriGene Technologies, Inc.
  • ProMab Biotechnologies, Inc.
  • ProteoGenix SAS
  • QIAGEN N.V.
  • Synbio Technologies LLC
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 4.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.7 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned40

Related Topics

Related Reports

Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase, Chip-based), By Research Phase (Pre-clinical, Clinical), By Application, By Service, By End-use, And Segment Forecasts, 2023 - 2030 - Product Image

Gene Synthesis (Research Use) Market Size, Share & Trends Analysis Report By Method (Solid-phase, Chip-based), By Research Phase (Pre-clinical, Clinical), By Application, By Service, By End-use, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Global Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Forecast 2024-2030 - Product Image

Global Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Gene Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - Product Image

Gene Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030

  • Report
  • 220 Pages
  • Global
Gene Synthesis Market Global Market Report 2024 - Product Image

Gene Synthesis Market Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Gene Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Image

Gene Synthesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From

About the Gene Synthesis Market

Gene Synthesis is a technology used in genomics to create custom DNA sequences. It involves synthesizing a gene from its component nucleotides, which are then assembled into a single strand of DNA. The technology is used in a variety of applications, including gene therapy, drug discovery, and agricultural biotechnology. It is also used to create custom DNA libraries for research and development. Gene Synthesis is a rapidly growing market, driven by advances in sequencing technology and the increasing demand for custom DNA sequences. The technology is used in a variety of industries, including pharmaceuticals, biotechnology, and agriculture. It is also used in academic research and in the development of new diagnostic tests. Companies in the Gene Synthesis market include GenScript, DNA2.0, Twist Bioscience, Eurofins Genomics, and Genewiz. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.